FDA halts Intellia gene-editing trial over liver issues
The FDA clinical hold covers two Phase 3 studies for nexiguran ziclumeran, or nex-z, an experimental gene-editi...Read More
How cuts decimated the government's mental health and addiction agency
SAMHSA's staff has been reduced by more than half, alarming local governments, nonprofits, and behavioral health providers. November 1, ...Read More
Subscribe to:
Comments
(
Atom
)